1. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study. (June 2021) Authors: Avouac, Jérôme; Drumez, Elodie; Hachulla, Eric; Seror, Raphaèle; Georgin-Lavialle, Sophie; El Mahou, Soumaya; Pertuiset, Edouard; Pham, Thao; Marotte, Hubert; Servettaz, Amélie; Domont, Fanny; Chazerain, Pascal; Devaux, Mathilde; Claudepierre, Pascal; Langlois, Vincent; Mekinian, Arsène; Maria, A... Journal: Lancet Issue: Volume 3:Number 6(2021) Page Start: e419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Rosuvastatin-Induced Dysarthria: An Unusual Drug Reaction. Issue 12 (December 2022) Authors: Barus, Romain; Jouvray, Mathieu; Gautier, Sophie; Potey, Camille Journal: Annals of pharmacotherapy Issue: Volume 56:Issue 12(2022) Page Start: 1382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases). Issue 2 (1st November 2022) Authors: Gottenberg, Jacques-Eric; Chaudier, Aurore; Allenbach, Yves; Mekinian, Arsène; Amoura, Zahir; Cacoub, Patrice; Cornec, Divi; Hachulla, Eric; Quartier, Pierre; Melki, Isabelle; Richez, Christophe; Seror, Raphaele; Terrier, Benjamin; Devauchelle-Pensec, Valérie; Henry, Julien; Gatfosse, Marc; Bouil... Journal: RMD open Issue: Volume 8:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗